CGEN
Compugen
NASDAQ: CGEN · HEALTHCARE · BIOTECHNOLOGY
$2.66
+2.31% today
Updated 2026-04-30
Market cap
$268.77M
P/E ratio
7.45
P/S ratio
3.69x
EPS (TTM)
$0.38
Dividend yield
—
52W range
$1 – $3
Volume
0.4M
Compugen (CGEN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+26.7%
Last 4 quarters
Revenue YoY growth
+4477.3%
Most recent quarter
EPS YoY growth
+957.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+4.3%
Last 2 reports
Positive reaction rate
100%
2 of 2 quarters
Largest single-day move
+6.2%
2025-11-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-19 | $0.60 | +900.0% | $1.70 | $1.74 | +2.4% |
| 2025-11-10 | $-0.07 | +0.0% | $1.62 | $1.72 | +6.2% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.08 | $0.60 | +900.0% | $67.33M | +4477.3% |
| 2025-09-30 | $-0.07 | $-0.07 | +0.0% | $1.89M | -89.0% |
| 2025-06-30 | $-0.06 | $-0.08 | -33.3% | $1.26M | -81.2% |
| 2025-03-31 | $-0.05 | $-0.08 | -60.0% | $2.28M | -10.7% |
| 2024-12-31 | $-0.08 | $-0.07 | +6.7% | $1.47M | -95.6% |
| 2024-09-30 | $0.10 | $0.01 | -85.8% | $17.13M | — |
| 2024-06-30 | $-0.07 | $-0.02 | +71.4% | $6.70M | — |
| 2024-03-31 | $-0.02 | $-0.08 | -300.0% | $2.56M | — |
| 2023-12-31 | $0.23 | $0.11 | -52.2% | $33.46M | — |
| 2023-09-30 | $-0.09 | $-0.11 | -22.2% | — | — |
| 2023-06-30 | $-0.12 | $-0.11 | +8.3% | — | — |
| 2023-03-31 | $-0.12 | $-0.11 | +8.3% | — | — |
Frequently asked questions
Has Compugen beaten earnings estimates?
Compugen has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +26.7% over the last 4 quarters.
How does CGEN stock react to earnings?
CGEN stock has moved an average of +4.3% in the trading day following earnings over its last 2 reports, with positive reactions in 100% of those quarters.
What is Compugen's revenue growth rate?
Compugen reported year-over-year revenue growth of +4477.3% in its most recent quarter, with EPS growing +957.1% year-over-year.